U.S. Pharmacist eNewsletter
August 2022

Hidden Active Ingredients Found in Honey-Based Products
Sildenafil citrate (Viagra) and tadalafil (Cialis) were discovered in some honey-based products, posing potential health risks to the general public. The FDA issued warnings to companies suspected of such behavior, along with descriptions of the violations in question. While extemporaneous compounding with these active ingredients is possible, in this case, mixing undeclared ingredients into consumer-based products is not a form of compounding. Read more.


Zonisamide Oral Suspension Approved by the FDA
The first oral suspension of Zonisade (zonisamide) 100 mg/5 mL (Eton Pharmaceuticals, Azurity Pharmaceuticals) was approved in July 2022 as an adjunctive treatment for adults and patients aged 16 years and older suffering from epilepsy. With this new formulation, patients who are unable to take solid dosage forms such as tablets or capsules now have another treatment option. Read more.

Amlodipine 1 mg/mL in Oral Mix Suspension Vehicle
Amlodipine besylate is a 1,4-dihydropyridine derivative calcium channel blocker with an intrinsically long duration of action. Amlodipine is used alone or in combination with other classes of antihypertensive agents in the management of hypertension, and it also is used to treat angina. The agent is well absorbed orally, with an onset of action of 20 to 50 minutes and a duration of effect of 24 hours. Read more.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App